首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
【24h】

Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.

机译:作为多巴胺D3受体配体的新苯并内酰胺衍生物的合成,结合亲和力和SAR。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new benzolactam derivatives was synthesized and the derivatives were evaluated for their affinities at the dopamine D(1), D(2), and D(3) receptors. Some of these compounds showed high D(2) and/or D(3) affinity and selectivity over the D(1) receptor. The SAR study of these compounds revealed structural characteristics that decisively influenced their D(2) and D(3) affinities. Structural models of the complexes between some of the most representative compounds of this series and the D(2) and D(3) receptors were obtained with the aim of rationalizing the observed experimental results. Moreover, selected compounds showed moderate binding affinity on 5-HT(2A) which could contribute to reducing the occurrence of extrapyramidal side effects as potential antipsychotics.
机译:合成了一系列新的苯并内酰胺衍生物,并评估了它们在多巴胺D(1),D(2)和D(3)受体上的亲和力。这些化合物中的某些显示出比D(1)受体更高的D(2)和/或D(3)亲和力和选择性。这些化合物的SAR研究揭示了决定性地影响其D(2)和D(3)亲和力的结构特征。为了使观察到的实验结果合理化,获得了该系列中一些最具代表性的化合物与D(2)和D(3)受体之间的配合物的结构模型。此外,选定的化合物显示出对5-HT(2A)的中等结合亲和力,这可能有助于减少作为潜在的抗精神病药的锥体外系副作用的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号